Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02689843Early Phase 1Completed
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Polycystic Ovary Syndrome
PrincipalinvestigatorStart date: 2018-02-01
NCT02704494Early Phase 1Completed
Resveratrol's Effects in Diabetic Nephropathy
Diabetic Nephropathy
PrincipalinvestigatorStart date: 2016-03-01

Research Network

Collaboration Network

8 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02689843Early Phase 1PrincipalInvestigator

Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS

Polycystic Ovary Syndrome
Completed
NCT02704494Early Phase 1PrincipalInvestigator

Resveratrol's Effects in Diabetic Nephropathy

Diabetic Nephropathy
Completed

All 2 trials loaded